|Functional exhaustion of CD4+ T cells induced by co‐stimulatory signals from myeloid leukaemia cells|
D Ozkazanc, D Yoyen‐Ermis, E Tavukcuoglu, Y Buyukasik, G Esendagli
Immunology 149 (4), 460-471, 2016
|Serial immunological parameters in a phase II trial of exemestane and low-dose oral cyclophosphamide in advanced hormone receptor-positive breast cancer|
M Kwa, X Li, Y Novik, R Oratz, K Jhaveri, J Wu, P Gu, M Meyers, F Muggia, ...
Breast Cancer Research and Treatment 168 (1), 57-67, 2018
|Myeloid maturation potentiates STAT3-mediated atypical IFN-γ signaling and upregulation of PD-1 ligands in AML and MDS|
D Yoyen-Ermis, G Tunali, E Tavukcuoglu, U Horzum, D Ozkazanc, T Sutlu, ...
Scientific reports 9 (1), 1-11, 2019
|PD‐L2+ wound zone macrophage‐like cells display M1/M2‐mixed activation and restrain the effector Th1 responses|
E Tavukcuoglu, U Horzum, KB Yilmaz, G Esendagli
Immunology and Cell Biology 98 (2), 152-164, 2020
|Combination drug delivery with actively-targeted PLGA nanoparticles to overcome multidrug resistance in breast cancer|
H Tonbul, A Sahin, E Tavukcuoglu, G Esendagli, Y Capan
Journal of Drug Delivery Science and Technology 54, 101380, 2019
|A Novel Missense LIG4 Mutation in a Patient With a Phenotype Mimicking Behçet’s Disease|
EZ Taskiran, HE Sonmez, C Kosukcu, E Tavukcuoglu, G Yazici, ...
Journal of clinical immunology 39 (1), 99-105, 2019
|Development and in vitro evaluation of a new adjuvant system containing Salmonella Typhi porins and chitosan|
S Yüksel, M Pekcan, N Puralı, G Esendağlı, E Tavukçuoğlu, ...
International Journal of Pharmaceutics 578, 119129, 2020
|Aggregation of chitosan nanoparticles in cell culture: Reasons and resolutions|
K Ozturk, FB Arslan, E Tavukcuoglu, G Esendagli, S Calis
International Journal of Pharmaceutics 578, 119119, 2020
|Protocol to assess the suppression of T-cell proliferation by human MDSC|
AM Bruger, C Vanhaver, K Bruderek, G Amodio, E Tavukçuoğlu, ...
Methods in Enzymology 632, 155-192, 2020
|Human splenic polymorphonuclear myeloid‐derived suppressor cells (PMN‐MDSC) are strategically located immune regulatory cells in cancer|
E Tavukcuoglu, U Horzum, H Yanik, A Uner, D Yoyen‐Ermis, SK Nural, ...
European Journal of Immunology, 2020
|Design and synthesis of novel peptidomimetics for cancer immunotherapy.|
C Köse, E Uysal, Z Tuğay, Sİ Dingiş Birgül, H Yanık, E Tavukçuoğlu, ...
Organic Communications 13 (3), 2020
|STAT3-mediated atypical IFN-gamma signaling modulates the PD-1 ligands in CD11b-positive subpopulation of MDS and AML cells|
D Yoyen-Ermis, G Tunali, E Tavukcuoglu, D Ozkazanc, T Sutlu, ...
EUROPEAN JOURNAL OF IMMUNOLOGY 49, 90-90, 2019